Skip to main content

Hi, I'm Dr. Alistair Tiefenbacher, a Data Scientist, Bioinformatician & Statistician living in Austria

Bridging cutting-edge research with real-world healthcare applications through AI and machine learning. Explore my journey from cancer genomics research to AI-powered medical devices.

About Me

With over a decade of experience in data science and bioinformatics at top institutions worldwide, I've led the development of AI-powered medical diagnosis systems achieving >90% diagnostic accuracy. My work spans cancer genomics research at Cambridge, protein structure prediction at Oxford, electronic health record screening at Symptoma, and now digital health innovation at Xund. I specialize in translating complex biological and medical data into actionable insights through machine learning, having published 15+ peer-reviewed papers in Nature, Cancer Research, and other leading journals. My unique strength lies in bridging the gap between cutting-edge research and real-world healthcare applications, from developing COVID-19 screening tools used by governments to pioneering personalized cancer treatment strategies.

Research

My research focuses on the intersection of artificial intelligence and healthcare, with expertise spanning three key areas: Medical AI Systems - developing and certifying diagnostic algorithms that meet regulatory standards; Cancer Genomics - analyzing tumor heterogeneity and drug response patterns using machine learning; and Digital Health Innovation - creating scalable solutions for population health monitoring and personalized medicine.

At Xund, I lead the company-wide transition to scalable ML frameworks to enable sustainable product development. Further, I provide the technical expertise for medical AI certification, ensuring our machine learning models meet the stringent requirements for clinical deployment. My approach combines rigorous statistical validation with real-world clinical testing, bridging the gap between research innovation and practical healthcare applications. I believe in developing AI systems that augment rather than replace clinical expertise, creating tools that empower healthcare providers to make better decisions for their patients.

Education

University of Oxford logo

2012-2017: Doctor of Philosophy (PhD) in Statistics

Department of Statistics, University of Oxford, United Kingdom

University of Edinburgh logo

2007-2012: Master of Chemical Physics, 1st Class Hons, Industrial Exp.

Department of Chemistry, University of Edinburgh, United Kingdom

Nanyang Technological University logo

2010-2011: International Exchange Student

Department of Chemistry, Nanyang Technological University, Singapore

Research Experience

Xund logo

2024 onwards: Senior Data Scientist, Xund, Vienna

Led company transition to scalable ML-frameworks for improved product development and medical product certification.

Symptoma logo

2021-2024: Chief Data Scientist, Symptoma, Vienna

Pioneered digital health solutions focusing on electronic health records and symptom checker development.

Symptoma logo

2020-2021: Senior Data Scientist, Symptoma, Vienna

Developed data-driven digital health products including COVID-19 diagnostic screening tools for government use.

University of Cambridge logo

2017-2020: Postdoctoral Researcher, CRUK, University of Cambridge

Multi-faceted investigation into breast cancer and its heterogeneity at the transcriptional level.

University of Oxford logo

2013-2017: Doctoral Student, University of Oxford

Investigating the structural information contained within mRNA above and beyond the mere specification of the amino acid.

UCB Pharma logo

2015: Visiting Researcher, UCB

Building a web platform for the identification and tracking of disruptive technologies.

University of Oxford logo

2013: Rotation Student, University of Oxford

Developing a new mathematical framework for cellular modelling that captures the physical properties of monolayers.

University of Edinburgh logo

2011-2012: Masters Student, University of Edinburgh

Determination of the hydrogenation pathway of ethylene on a Pt(111) surface using first-principle techniques.

UC Berkeley logo

2011: Visiting Academic, UC Berkeley

Exploring the possibilities of using polarisation in ultrafast Raman spectroscopy to reduce the HL(III) and HL(IV) contributions to the spectrum.

A*STAR Institute logo

2011: Student Researcher, A*STAR Institute of High Performance Computing

Theory and simulations of solute cage formation around dissolved gasses and determination of partial molar volumes.

Nanyang Technological University logo

2010-2011: Student Researcher, Nanyang Technological University

Theory and simulations of the effects of polarisation in ultrafast Raman spectroscopy on third-order cascade effects observed in deuterated chloroform.

Max Planck Institute logo

2009: Research Assistant, Max-Planck Institute for Iron Research

Electrochemical characterisation via a scanning droplet cell of binary and tertiary metal gradients created by physical vapour deposition.

Publications

Cancer Research & Precision Medicine

Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast Cancer
Cancer Research, DOI: 10.1158/0008-5472.CAN-24-1703 (2025)

A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival
Molecular Oncology, DOI: 10.1002/1878-0261.70015 (2024)

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
Nature Communications, DOI: 10.1038/s41467-021-22303-z (2021)

Landscape of G-quadruplex DNA structural regions in breast cancer
Nature Genetics, DOI: 10.1038/s41588-020-0672-8 (2020)

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer
Cancer Cell, DOI: 10.1016/j.ccell.2020.08.016 (2020)

Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells
Nature Cell Biology, DOI: 10.1038/s41556-018-0140-1 (2018)

Digital Health & Medical AI

Multilingual Framework for Risk Assessment and Symptom Tracking (MRAST)
Sensors, DOI: 10.3390/s24041101 (2024)

Machine Learning Algorithms to Predict Breast Cancer Recurrence Using Structured and Unstructured Sources from Electronic Health Records
Cancers, DOI: 10.3390/cancers15102741 (2023)

An artificial intelligence-based approach for identifying rare disease patients using retrospective electronic health records applied for Pompe disease
Frontiers in Neurology, DOI: 10.3389/fneur.2023.1108222 (2023)

Correlating global trends in COVID-19 cases with online symptom checker self-assessments
PLOS ONE, DOI: 10.1371/journal.pone.0281709 (2023)

An artificial intelligence-based first-line defence against COVID-19: digitally screening citizens for risks via a chatbot
Scientific Reports, DOI: 10.1038/s41598-020-75912-x (2020)

Diagnostic Accuracy of Web-Based COVID-19 Symptom Checkers: Comparison Study
Journal of Medical Internet Research, DOI: 10.2196/21299 (2020)

Academic & Methodological

10 simple rules for surviving an interdisciplinary PhD
PLoS Computational Biology, DOI: 10.1371/journal.pcbi.1005512 (2017)

Variation and decomposition of the partial molar volume of small gas molecules in different organic solvents derived from molecular dynamics simulations
The Journal of Chemical Physics, DOI: 10.1063/1.4854135 (2013)

Theoretical simulation and preparation of binary and ternary combinatorial libraries by thermal PVD
Physica Status Solidi A, DOI: 10.1002/pssa.200983302 (2010)

Contact

For professional inquiries, collaboration opportunities, or research discussions

Connect with me professionally and stay updated on my latest work

Explore my open-source contributions and research code